Extendicare Inc. (TSE:EXE – Free Report) – Leede Financial boosted their FY2025 earnings per share (EPS) estimates for Extendicare in a report issued on Wednesday, November 13th. Leede Financial analyst D. Loe now expects that the company will post earnings per share of $1.29 for the year, up from their prior estimate of $0.90. The consensus estimate for Extendicare’s current full-year earnings is $0.61 per share. Leede Financial also issued estimates for Extendicare’s FY2026 earnings at $1.39 EPS.
EXE has been the subject of a number of other research reports. Royal Bank of Canada lifted their price target on shares of Extendicare from C$8.50 to C$9.50 in a research note on Monday, August 19th. TD Securities lifted their target price on shares of Extendicare from C$9.50 to C$10.50 and gave the company a “hold” rating in a report on Thursday.
Extendicare Trading Up 1.3 %
Shares of TSE EXE opened at C$10.14 on Monday. The stock has a fifty day simple moving average of C$9.27 and a 200-day simple moving average of C$8.16. The company has a current ratio of 0.60, a quick ratio of 0.98 and a debt-to-equity ratio of 305.80. Extendicare has a twelve month low of C$6.41 and a twelve month high of C$10.43. The stock has a market capitalization of C$846.39 million, a PE ratio of 14.91 and a beta of 1.26.
Extendicare Dividend Announcement
The company also recently announced a monthly dividend, which was paid on Friday, November 15th. Shareholders of record on Thursday, October 31st were given a dividend of $0.04 per share. The ex-dividend date was Thursday, October 31st. This represents a $0.48 dividend on an annualized basis and a yield of 4.73%. Extendicare’s payout ratio is 70.59%.
Extendicare Company Profile
Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.
See Also
- Five stocks we like better than Extendicare
- How to Use the MarketBeat Dividend Calculator
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.